Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clay Siegall
Biotech
Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders
Bradner returns from brief break to lead Amgen R&D. Genentech's interim CEO given the permanent job. Moderna ousts commercial chief Garay.
Max Bayer
,
Gabrielle Masson
Dec 15, 2023 9:30am
Immunome, Morphimmune reverse merge with Clay Siegall as CEO
Jun 29, 2023 10:50am
Former Seagen CEO takes new role less than a year after arrest
Mar 23, 2023 11:20am
